Despite great progress in diagnosis and management of hepatocellular carcinoma (HCC),
the exact biology of the tumor remains poorly understood overall limiting the patients'
outcome. Detailed analysis and characterization of the molecular mechanisms and
subsequently individual prediction of corresponding prognostic traits would revolutionize
both diagnosis and treatment of HCC and is the key goal of modern personalized medicine.
Over the recent years systematic approaches for the analysis of whole tumor genomes and …